Patent · US Active

Implantable device for controlled drug delivery

US9017312B2 · kind B2 · utility

26Cited by
65References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2010
Grant dateApr 28, 2015
Priority date
Expiry dateMar 31, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/1085
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Implantable devices and methods for delivery of lidocaine or other drugs to a patient are provided. In one embodiment, the device includes a first drug portion which has a first drug housing which contains a first drug formulation in a solid form which includes a pharmaceutically acceptable salt of lidocaine; and a second drug portion which includes a second drug housing which contains a second drug formulation which includes lidocaine base. In another embodiment, the device includes a drug reservoir component which has an elastic tube having at least one lumen bounded by a porous sidewall having an open-cell structure, a closed-cell structure, or a combination thereof; and a drug formulation contained within the at least one lumen, wherein the device is deformable between a low-profile deployment shape and a relatively expanded retention shape.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.